AI could spot rare brain complication after carotid surgery
NCT ID NCT05800821
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing whether a deep learning model can predict cerebral hyperperfusion syndrome (CHS), a rare but serious brain complication that can occur after carotid artery surgery. Researchers will enroll 500 adults aged 30-80 who are having carotid revascularization. The goal is to identify patients at risk early, so doctors can intervene and prevent severe outcomes.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could lead to a tool that helps doctors predict and prevent a rare but serious brain complication after carotid artery surgery.
What could go wrong
This is an observational study, not a treatment trial. The deep learning model may not be accurate enough for real-world use, and results may not apply to all patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CAROTID ATHEROSCLEROSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
State Institution "Republican Scientific and Practical Center "Cardiology"
RECRUITINGMinsk, Belarus
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••